Abstract. Although intrarenal infusions of kinins produce diuresis, it is not clear to what extent this response is due to hemodynamically mediated medullary washout and/or to direct epithelial effects ofkinins. Recent evidence has shown that bradykinin binds to collecting tubules in vitro. We therefore examined the interactions of lysyl-bradykinin and antidiuretic hormone (ADH) with respect to hydraulic conductivity (L,) in the rabbit cortical collecting tubule perfused in vitro. To ensure adequate substrate for prostaglandin synthesis, the bath contained 2.5 qM arachidonic acid. Arachidonic acid produced no change in base-line lp and had no effect on the subsequent response to a supramaximal dose of ADH (100 ,U/ml).
Introduction
The exact physiologic role of the renal kallikrein-kinin system remains unclear. Clearance studies have shown that infusion of kinins into the renal artery produces natriuresis and diuresis (1) (2) (3) (4) . Micropuncture and tissue-tonicity studies have further suggested that bradykinin-induced redistribution of blood flow toward the medulla and the resulting medullary washout could, at least in part, account for these effects (5, 6) . On the other hand, recent enzymatic and anatomic data suggest an action of the kallikrein-kinin system within the cortex. In the rabbit and rat kidney, kallikrein and prekallikrein have been localized to the connecting segment (7, 8) . Although it is clear that kallikrein is a protease which converts low molecular weight kininogen to lysyl-bradykinin (LBK)' (9) , it is not known if the latter is generated in the lumen of the connecting segment, in the peritubular blood, or both. Bradykinin has also recently been shown to bind specifically to cortical and medullary collecting tubules of the rabbit (10) . In concert, these findings suggest that the kallikrein-kinin system, at least within the cortex, may act to modulate tubule transport directly from the basolateral and/or apical membrane. We therefore studied the effects of LBK on base-line and antidiuretic hormone (ADH)-stimulated osmotic water flow in the rabbit cortical collecting tubule. The data show that LBK from the bath side, but not the lumen, inhibits water flow due to a supramaximal dose ofADH, and that this inhibition is probably mediated via prostaglandin synthesis.
Methods
General microperfusion methods. In vitro microperfusion of cortical collecting tubules followed the general methods of Burg and Orloff(I 1). Briefly, normal female New Zealand white rabbits weighing 1.5-2.5 kg were killed by decapitation. The left kidney was quickly removed and 1-2-mm coronal slices were cut and placed in chilled, oxygenated Ringersbicarbonate at pH 7.4. Dissection of tubules was done in the same bath as was used for perfusion experiments (below).
Cortical collecting tubules were freehand dissected at 4VC using sharpened forceps with the aid of a dissection microscope. The cortical ends ofthe tubules were cutjust distal to theirjunction with a connecting segment. Tubules were not used if this junction occurred more than one-third of the way into the cortex from the cortical surface. Care was taken not to touch the tubules except at the ends. Tubules were transferred to a thermostatically-controlled chamber of 1 cm3 volume containing ports for constant inflow and removal of bath. The tubules were sucked into holding pipettes containing elastomeric silicone resin (Sylgard 184, Dow Coming Corp., Midland, MI) and cannulated with an inner perfusion pipette. All tubules were perfused in an orthograde direction. Fluid from the tubules was collected under water-equilibrated mineral oil into a calibrated volume pipette (CVP). The volume of the CVP was determined by daily calibration: at the end of the experiment, the perfusion pipette was advanced into a second pipette containing a short (200 ,m) column of Sylgard backed by mineral oil; perfusate was forced between the Sylgard and oil, and the CVP was filled in triplicate at 370C from this perfusate.
Solutions. Tubules were always bathed in a bath containing (in mM): Na, 145; Cl, 112; HCO3, 25; K, 5; Ca, 2.4; P04, 2.3; Mg, 1.0; S04, 1.0; acetate, 10; glucose, 8; alanine, 5; and bovine serum albumin, 6 g/100 ml (CRG-7, Armour Pharmaceutical Co., Tarrytown, NY). The osmolarity of the bath was 295 mOsM/kg. Tubules were initially perfused with a perfusate identical in composition to the bath except without bovine albumin. The tubules were warmed to 370C and allowed to equilibrate for 60-90 min. The perfusate was then changed to one of identical composition except that the NaCl concentration was 15 mM (osmolarity = 132 mOsM/kg), and another 90 min were allowed. This second perfusate also contained [3H]methoxy-inulin (New England Nu- clear, Boston, MA) exhaustively dialyzed by the method of Schafer et al. (12) . Baths were bubbled at 37°C with 95% 02:5% CO2 to pH 7.40, drawn anaerobically into syringes, and pumped through the perfusion chamber at .0.6 cm3/min. Osmolarities base-line Lp measurements were made after 180-min equilibration at 370C (15) , then a maneuver was performed, and then Lp was measured again over the next 30 min. In protocol 1, the maneuver performed was the addition of arachidonic acid (2.5 MM) to the bath. In protocol 2, the maneuver was a sham bath change, and thus, this protocol served as a time control. In protocol 3, the maneuver was the addition of LBK (l0-9 M) to the bath, and in protocol 4, it was LBK addition to the perfusate. In protocols 2-4, arachidonic acid (2.5 uM) was present in the bath from the onset of perfusion.
In contrast, protocols 5-9 examined the effect ofvarious preexposure conditions on the Lp response to ADH (100 MU/ml). In each case, Lp was measured before, and for at least 45 min following, the addition of ADH (100 ,uU/ml) to the bath. In protocol 5, the ADH response was assessed in unmodified bath (no arachidonic acid present). In protocol 6, the ADH response was measured with arachidonic acid (2.5 MUM)
present from the onset of perfusion. In protocol 7, the bath contained LBK (l0-9 M) for I h before 4 measurements. In protocol 8, the bath contained indomethacin (5 MM) from the start of perfusion, plus LBK (10-9 M) for I h before Lp measurements. In protocol 9, the perfusate contained LBK (10-9 M) for 1 h before Lp measurements. In protocols 6-9, arachidonic acid (2.5 MuM) was present in the bath from the onset of perfusion. Reagents. Arachidonic acid (99% purity) and LBK were purchased from Sigma Chemical Co. (St. Louis, MO). The arachidonic acid was kept frozen in the dark under inert gas as a 25 mM stock solution in 0.1 M Tris, pH 8. All bath infusion syringes containing arachidonic acid were kept covered with aluminum foil during the experiment to minimize oxidation. LBK was kept frozen as aliquoted 1 ,ug/,ul stock in Ringers plus 2% bovine albumin and thawed daily as needed. ADH (Arg-Vasopressin, Calbiochem-Behring Corp., San Diego, CA) was kept refrigerated as an aqueous stock solution (0.5 mg/ml). Indomethacin (Sigma Chemical Co.) was aliquoted and kept frozen as a I mg/ml stock in 75 mM NaCO3.
Statistics. Perfusion rates, J, and 4, from three to four collections on a given tubule were meaned; then, this value became the value for that tubule for that experimental period. The value "n" equals number of tubules. Since protocols 1-4 studied the effect of a given maneuver on base-line Lp in the same tubule, the two-tailed paired t test was used. In addition, protocols 1, 3, and 4 were compared with protocol 2 (time control) by two-way analysis ofvariance (16) . In protocols 5-9, a control group of tubules was compared with each of several experimental groups, also by two-way analysis of variance. Differences were considered significant if P < 0.05.
Results
Base-line LP: arachidonic acid. Arachidonic lowing ADH (by unpaired analysis). Therefore, for comparisons to subsequent experimental groups, all tubules in Table V were combined as a single control group with mean values as shown Table V . A second group was exposed to bath LBK (10-9 M) for 1 h before ADH was added (vertical-line bars). A third group was exposed to bath LBK and indomethacin (5 MM) for 1 h before ADH (diagonal-line bars). *, P < 0.02; ** = P < 0.01 compared with control group, bath LBK plus indomethacin group, and lumen LBK group (Table VIII) by analysis of variance.
at the bottom of Table V . As shown in Fig. 1 spectively. These differences were significantly different from the control group ADH response (see Fig. 1 was inhibited by both kinins. Second, since the toad bladder contains all components ofthe kallikrein-kinin cascade, another approach has been to inhibit kallikrein protease activity with aprotinin. Depending upon the species of toad, this maneuver has been reported to either have no effect (20) or to stimulate ADH-mediated water flow (21) . Likewise, enhancement of endogenous kinin levels in the toad bladder by kininase inhibitors has led to inhibition of the osmotic response to ADH (21) . In both the studies of Orce et al. (20) and Carvounis et al. (21), manipulation of the toad bladder endogenous kallikrein-kinin system produced no effect on non-ADH-stimulated (base-line) water flow. In concert, this evidence from the toad bladder has suggested that kinins inhibit ADH-mediated water flow, but do not alter basal water permeability. The present studies using isolated, perfused collecting tubules agree, at least qualitatively, with these previous toad bladder data.
In our studies, the inhibition ofADH action by preexposure to bath LBK was completely reversed by indomethacin, suggesting a role for prostaglandins in this bradykinin effect. Bradykinin has been reported to stimulate prostaglandin E2 synthesis in cultured dog cortical collecting duct cells (22) and in MDCK cells (which have some properties in common with collecting ducts) (23) at the concentration (10-9 M) used here. Also, it has been known since the studies of Grantham and Orloff (24) in the cortical collecting tubule and Orloffet al. (25) in the toad bladder that prostaglandin El can inhibit the hydroosmotic response to ADH, at least in part (26) by inhibiting the generation of cyclic AMP. Our experiments are therefore consistent with a model in which bradykinin stimulates endogenous prostaglandin synthesis in cortical collecting tubules, such that the subsequent hydroosmotic action of ADH is, in turn, inhibited by these prostaglandins.
Two important points should be made concerning this interpretation, however. First, it is possible that part ofthe increase in Lp seen in the indomethacin-treated tubules was due to phosphodiesterase inhibition. Flores and Sharp (27) reported about 15-20% inhibition of phosphodiesterase activity in the toad urinary bladder by indomethacin at the concentration (5 JAM) used here. It is unclear, however, whether this action ofthe drug produces a quantitatively significant effect on water flow. Indomethacin alone does not alter basal water flow in the toad bladder (28, 29) . Moreover, even when toad bladder phosphodiesterase activity is inhibited virtually 100% by theophylline (27), the resulting water flow is still only a fraction of that seen at low doses ofADH (30). Indomethacin does not alter rat renal medullary phosphodiesterase activity (31, 32) , and in contrast to its effects in the toad bladder, in the case ofisolated, perfused cortical collecting tubules bathed in arachidonic acid, indomethacin does not augment Lp in response to submaximal ADH (18) . As far as we are aware, the effect of indomethacin on phosphodiesterase activity in rabbit cortical collecting tubules has not been directly determined. On the whole, however, we feel that the most likely mechanism for indomethacin-induced reversal of the bradykinin effect reported here is inhibition of prostaglandin synthesis.
The second point concerning the apparent prostaglandin mediation ofbradykiniri's effect concerns the temporal sequence ofthese experiments. Our data show that preexposure oftubules to bradykinin blunts the subsequent ADH response. It is not clear that bradykinin added after ADH would have had an identical effect. We performed these experiments at 37°C because, based on the data of Hall and Grantham (15), we were unsure whether or not cortical collecting tubules can synthesize prostaglandins normally at room temperature. If, at 37°C, the decline in Lp which begins about 45 min post-ADH (15) is due to prostaglandin synthesis, then the blunted Lp seen at 30-min post-ADH in our bradykinin-exposed tubules may have represented an experimental condition in which ADH-mediated prostaglandin synthesis had not yet peaked. The sequential exposure to the two peptides which we employed may not necessarily occur in vivo; rather, the epithelium might be exposed to bradykinin during maximal ADH-induced prostaglandin synthesis. If this were the case, a further reduction in Lp by bradykinin might depend on whether or not bradykinin and ADH stimulate the same prostaglandin end products and/or share a common intracellular pool ofarachidonic acid. We have not addressed this reverse sequence ofpeptide exposure because of the difficulties inherent in interpreting falling Lp at 37°C.
We used arachidonic acid in the bathing medium to ensure optimal conditions for hormone-mediated prostaglandin synthesis. Moreover, we sought a concentration ofarachidonic acid which would minimize nonspecific augmentation of prostaglandin synthesis but still allow hormone-mediated stimulation to occur. In this regard, Schwartzman et al. (33) found, in the isolated perfused rabbit kidney, that 6.6 ,M arachidonic acid produced only a 50% increase in prostaglandin synthesis, whereas bradykinin produced a nearly 1,200% increase. Similarly, in the colon, even an arachidonic acid concentration of 0.5 mM (200-fold the present dose) failed to quantitatively mimic the action of bradykinin on chloride transport (34). Kirschenbaum et al. (18) found that 50 MM arachidonic acid in the bath inhibited the hydroosmotic response ofin vitro cortical collecting tubules to 2.5 ,U/ml ADH. In contrast, Stokes (35) found that neither 10 nor 5 ,M arachidonic acid altered base-line water permeability or the response to I uU/ml ADH. These differences underscore the dose-dependent effect of exogenously added arachidonic acid on apparent endogenous prostaglandin synthesis rates. Our own data suggest that 2.5 MM arachidonic acid did not stimulate nonspecific prostaglandin production to an extent which would inhibit maximal ADH action, since the osmotic permeabilities with and without this dose of arachidonic acid were virtually identical (Table V) (22) , and it is quite close to the normal human urine LBK concentration (41) . The apparent sidedness (basolateral) for bradykinin's action demonstrated here appears inconsistent with immunohistochemical studies showing an apical location ofdistal nephron kallikrein (42) . It should be noted, however, that in the isolated perfused kidney, more kallikrein-like activity is spontaneously released into the venous effluent than into the urine per unit time (43) . Moreover, Yamada and Erdos (44) have recently reported isolation of a basolateral kallikrein from rat kidney with properties which are different from urinary kallikrein. Taken together, these studies and our data suggest that an action of bradykinin from the basolateral side in vivo is possible. Our negative luminal studies do not rule out the potential for bradykinin action from this membrane under certain conditions, however.
Finally, the present results help to further define the physiologic role of the renal kallikrein-kinin system. Water loading increases kallikrein excretion (9, 45) , suggesting activation of the kallikrein-kinin system. In addition, examination ofcircadian rhythms of urine volume and urinary kallikrein excretion during spontaneous drinking shows that these vary linearly with each other (46) . These studies thus suggest that kinin activation occurs during water diuresis when ADH levels are either declining or are suppressed. In this context, we have interpreted our data as showing no effect of kinins on osmotic water permeability in the absence of ADH; thus, it makes a regulatory role for bradykinin in the absence of ADH unlikely. However, we cannot absolutely rule out an LBK effect on base-line Lp. In percentage terms, bath LBK addition over 30 min appeared to decrease base-line Lp more (33%) than either lumen addition (5%) or time controls (13%), but this decrease was not statistically different from that seen in the time controls. After exposure to bath LBK for 1 h, the pre-ADH Lp (a "base-line" Lp term) was not significantly lower than similar measurements in control, lumen LBK, or bath LBK plus indomethacin groups, all of which were compared by analysis ofvariance (P = 0.053). However, analysis ofvariance is weighted toward avoiding an "alpha" error, i.e. concluding that two groups are different when they are not. Particularly with the relatively small sample size we employed, analysis of variance may commit a beta type II error; that is, it may conclude that no difference exists between two groups when such a difference does exist (16) . Therefore, it is possible that exposure to bath LBK for 1 h does indeed lower base-line Lp. Studies utilizing a large number of tubules would probably be needed in order to demonstrate such a difference.
On the other hand, administration of ADH to dogs and rats results in enhanced urinary kallikrein excretion (47, 48) and since infusions of bradykinin antagonize the action of ADH in clearance experiments (1), these studies have suggested that the kallikrein-kinin system may serve as a feedback inhibitor of ADH action. Although the examination of kallikrein excretion rates suffers the drawback that these determinations may not reflect rates of intraluminal or peritubular generation of LBK, urinary kinins have been correlated with diuresis in at least one study (49) . Thus, this second group ofstudies suggests activation of the kallikrein-kinin system when ADH levels are high. If our data represent a physiologic event, then the inhibition of ADH action by LBK would be consistent with activation of the kallikrein-kinin system at high ADH levels.
